Published in Clin Exp Immunol on October 01, 1991
Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes. Arthritis Res Ther (2010) 1.59
Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor. Clin Exp Immunol (2006) 0.89
Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol (2003) 0.88
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis. Arthritis Res (2001) 0.84
The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes. Sci Rep (2015) 0.79
The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro. Ann Rheum Dis (1994) 0.78
Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases. Drug Target Insights (2007) 0.75
Fibroblast growth factors in connective tissue disease associated interstitial lung disease. Clin Exp Immunol (1992) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med (1986) 9.86
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science (1985) 7.99
The biology of platelet-derived growth factor. Cell (1986) 7.17
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med (1986) 4.99
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum (1988) 4.60
Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med (1987) 4.54
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol (1988) 4.20
Fluorescein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal Biochem (1984) 4.17
Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature (1986) 2.94
Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest (1986) 2.82
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77
Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum (1983) 2.75
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med (1987) 2.62
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum (1977) 2.14
Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest (1980) 2.13
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages. J Clin Invest (1986) 1.80
Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med (1989) 1.77
Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J Immunol (1987) 1.73
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Modulation of fibroblast growth by a lymphokine of human T cell continuous T cell line origin. J Immunol (1983) 1.39
Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol (1986) 1.36
Significance of fibronectin in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis (1981) 1.35
Increased proliferation of human synovial fibroblasts treated with recombinant immune interferon. J Immunol (1985) 1.33
Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol (1990) 1.31
Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants. J Immunol (1981) 1.21
Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol (1987) 1.20
Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction. J Exp Med (1985) 1.20
Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis (1983) 1.19
Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. J Immunol (1989) 1.15
Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum (1987) 1.14
Different molecular forms of fibronectin in rheumatoid synovial fluid. Arthritis Rheum (1982) 1.14
The demonstration of an interleukin-2 like activity in the synovial fluids of rheumatoid arthritis patients. J Rheumatol (1983) 1.13
Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro. Biochem J (1983) 1.12
Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains. Arthritis Rheum (1986) 1.10
Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J Leukoc Biol (1990) 1.09
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids. Clin Exp Immunol (1984) 1.04
IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. J Immunol (1990) 1.04
Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol (1988) 1.04
Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities. J Leukoc Biol (1984) 1.02
Modulation of connective tissue metabolism by partially purified human interleukin 1. Cell Immunol (1985) 0.94
Rheumatoid and normal synovial tissue in longterm culture. Evidence of cell heterogeneity and an approach to quantitation of of populations and the effect of passage. J Rheumatol (1978) 0.90
Effect of retinoids on rheumatoid arthritis, a proliferative and invasive non-malignant disease. Ciba Found Symp (1985) 0.88
Cellular interactions and control of collagenase secretion in the synovium. J Rheumatol Suppl (1983) 0.80
The effect of lymphokines on proliferation and collagen synthesis of cultured human synovial cells. Eur J Clin Invest (1982) 0.80
Detection and partial characterization of human B cell colony stimulating activity in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol (1985) 0.80
Lymphocyte and macrophage derived fibroblast growth factors. Prog Clin Biol Res (1984) 0.77
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A (1997) 4.20
Depressed lymphocyte function after bereavement. Lancet (1977) 3.45
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? J Rheumatol (1994) 2.76
Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med (1993) 2.76
Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol Infect (1994) 2.70
Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med (1992) 2.65
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
AIDS behind bars: preventing HIV spread among incarcerated drug injectors. AIDS (1995) 2.40
Probing protein-protein interactions in real time. Nat Struct Biol (2000) 2.12
HIV exposure in health care. Med J Aust (1995) 2.04
Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust (1989) 2.02
Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med (1988) 1.92
[Osteosynthesis of the temporal articular tubercle]. Rev Stomatol Chir Maxillofac (2007) 1.91
Cells involved in the immune response. IV. The response of normal and immune rabbit bone marrow and lymphoid tissue lymphocytes to antigens in vitro. J Exp Med (1968) 1.89
CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS (1991) 1.85
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Absolute pulse energy measurements of soft x-rays at the Linac Coherent Light Source. Opt Express (2014) 1.73
Smoking-induced changes in epithelial lining fluid volume, cell density and protein. Eur Respir J (1992) 1.73
A surface active protein involved in aerial hyphae formation in the filamentous fungus Schizophillum commune restores the capacity of a bald mutant of the filamentous bacterium Streptomyces coelicolor to erect aerial structures. Mol Microbiol (1998) 1.71
Cement leakage during vertebroplasty: an underestimated problem? Eur Spine J (2005) 1.64
Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys (1995) 1.58
Systemic factors contributory to retinal vein occlusion. Arch Intern Med (1978) 1.57
Pulsed-field gel electrophoresis for epidemiologic studies of Campylobacter hyointestinalis isolates. J Clin Microbiol (1992) 1.55
Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood (1993) 1.54
Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis. J Infect Dis (1994) 1.54
Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis (1988) 1.52
Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution. J Biol Chem (2001) 1.49
Cells involved in the immune response. VI. The immune response to red blood cells in irradiated rabbits after administration of normal, primed, or immune allogeneic rabbit bone marrow cells. J Exp Med (1969) 1.48
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
[Staging laparoscopy in Hodgkin's disease. A valid alternative to staging laparotomy]. Dtsch Med Wochenschr (1993) 1.44
Preliminary investigation of frequency of vomiting by pigs in transport. Vet Rec (1996) 1.44
The use of Poller screws as blocking screws in stabilising tibial fractures treated with small diameter intramedullary nails. J Bone Joint Surg Br (1999) 1.44
The neurological features of early and 'latent' human immunodeficiency virus infection. Aust N Z J Med (1989) 1.42
Molecular cloning and expression of a chloride ion channel of cell nuclei. J Biol Chem (1997) 1.41
The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia (2006) 1.41
The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol (1985) 1.39
[Headache, hypertension]. Schweiz Rundsch Med Prax (1991) 1.38
Structural characterization of Dictyostelium discoideum prespore-specific gene D19 and of its product, cell surface glycoprotein PsA. Mol Cell Biol (1988) 1.37
Microplate reader-based quantitation of collagens. Anal Biochem (1992) 1.34
Correlation of serum follicular stimulating hormone (FSH) and luteinizing hormone (LH) as measured by radioimmunoassay in disorders of sexual development. J Clin Invest (1970) 1.31
Circulating immune complexes in retinal vasculitis. Clin Exp Immunol (1977) 1.30
4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta (1996) 1.29
The response of leucocytes of agammaglobulinaemia subjects to phythohaemagglutinin and anti-immunoglobulin antiserum. Clin Exp Immunol (1969) 1.29
Sequential arginine and insulin tolerance tests on the same day. J Clin Endocrinol Metab (1969) 1.25
H2-forming methylenetetrahydromethanopterin dehydrogenase, a novel type of hydrogenase without iron-sulfur clusters in methanogenic archaea. Eur J Biochem (1992) 1.24
High agreement on family affluence between children's and parents' reports: international study of 11-year-old children. J Epidemiol Community Health (2008) 1.23
Maternal weight and pregnancy complications. Am J Obstet Gynecol (1985) 1.23
Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol (2001) 1.20
Sexual maturation in subjects with sickle cell anemia: studies of serum gonadotropin concentration, height, weight, and skeletal age. J Pediatr (1975) 1.19
Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques (2002) 1.18
Human dermal microvascular endothelial cells: an improved method for tissue culture and a description of some singular properties in culture. In Vitro Cell Dev Biol (1985) 1.18
Acquired immune deficiency syndrome. Med J Aust (1983) 1.17
Antibody response to human immunodeficiency virus after primary infection. J Infect Dis (1987) 1.17
Behcet's syndrome: clinical, immunological and therapeutic evaluation of 17 patients. Aust N Z J Med (1974) 1.17
Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J Neurovirol (1995) 1.17
Trauma care in Germany. Injury (2003) 1.16
Seasonality of weather and tree phenology in a tropical evergreen mountain rain forest. Int J Biometeorol (2006) 1.16
The role of bone marrow in the immune response. Adv Immunol (1970) 1.16
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis (2007) 1.15
Cells involved in the immune response. XXII. The demonstration of thymus-specific antigens in the rabbit. Immunology (1972) 1.15
Studies on neutrophil function. II. Pathological aspects. Br J Haematol (1966) 1.15
The variation in response of human peripheral lymphocytes to phytohemagglutinin in vitro. Int Arch Allergy Appl Immunol (1967) 1.15
Comparison of direct and indirect arterial pressure measurements in hospitalized patients. Aust N Z J Med (1974) 1.15
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. Invest New Drugs (2006) 1.15
Pigeon-breeder's disease: study of the cell-mediated immune response to pigeon antigens by the lymphocyte culture technique. Int Arch Allergy Appl Immunol (1974) 1.14
Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest (1986) 1.14
Cow's milk allergy as a cause of infantile colic: immunofluorescent studies on jejunal mucosa. Aust Paediatr J (1977) 1.14
Studies on neutrophil function. 1. Physiological and pharmacological aspects. Br J Haematol (1966) 1.13
Photoelectric effect at ultrahigh intensities. Phys Rev Lett (2007) 1.13
The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab (2000) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Inflammation and haemostasis in paraproteinaemias. Br J Haematol (1971) 1.12
[Inadequate treatment compliance, patient information and drug prescription as causes for emergency hospitalization of patients with chronic heart failure]. Schweiz Med Wochenschr (1993) 1.12
Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS (1994) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Variables in the isolation and culture of human monocytes that are of particular relevance to studies of HIV. J Leukoc Biol (1994) 1.11
Similarity of primary radical pair recombination in photosystem II and bacterial reaction centers. FEBS Lett (1993) 1.10
The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J Physiol (2000) 1.09
Primary human immunodeficiency virus infection. Clinical and serologic aspects. Infect Dis Clin North Am (1988) 1.09
Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J Leukoc Biol (1990) 1.09
Uveitis: aetiology and disease associations in an Australian population. Aust N Z J Ophthalmol (1986) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Functional magnetic resonance imaging with intermolecular multiple-quantum coherences. Magn Reson Imaging (2000) 1.07
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. Br J Cancer (2010) 1.07
Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis (1993) 1.07
IgA-IgG cryoglobulinaemia with vasculitis. Clin Exp Immunol (1971) 1.06